Atropen

SandorMax developed a comprehensive branding program for AtroPenŽ, an auto-injector developed by King Pharmaceuticals to treat victims of terrorist attacks involving chemical nerve agents. The branding program included logo development, packaging design and standards guideline development, to ensure consistent branding of the new project across platforms. The selected design reflects the confidence, strength and fast response of this life-saving pharmaceutical product.